Bullock Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74.2K Buy
2,640
+10
+0.4% +$266 0.03% 245
2026
Q2
$62.8K Buy
2,630
+11
+0.4% +$288 0.03% 260
2026
Q1
$74.8K Buy
2,619
+34
+1% +$905 0.04% 238
2025
Q4
$64.4K Buy
2,585
+35
+1% +$883 0.03% 241
2025
Q3
$69.4K Buy
2,550
+1,411
+124% +$34.8K 0.03% 234
2025
Q2
$28.5K Sell
1,139
-821
-42% -$19.1K 0.02% 286
2025
Q1
$48.1K Sell
1,960
-365
-16% -$9.6K 0.03% 249
2024
Q4
$61.7K Buy
2,325
+1,550
+200% +$42K 0.04% 233
2024
Q3
$22.2K Buy
775
+9
+1% +$263 0.01% 303
2024
Q2
$21.6K Sell
766
-399
-34% -$11K 0.01% 292
2024
Q1
$32.3K Buy
1,165
+10
+0.9% +$277 0.02% 268
2023
Q4
$33.3K Sell
1,155
-7,953
-87% -$240K 0.03% 270
2023
Q3
$309K Sell
9,108
-504
-5% -$17.8K 0.26% 91
2023
Q2
$352K Buy
9,612
+442
+5% +$17.2K 0.28% 90
2023
Q1
$379K Sell
9,170
-1,081
-11% -$46.7K 0.34% 85
2022
Q4
$525K Sell
10,251
-26,161
-72% -$1.25M 0.52% 59
2022
Q3
$524K Buy
36,412
+25,234
+226% +$1.23M 0.55% 49
2022
Q2
$585K Buy
11,178
+293
+3% +$14.9K 0.61% 43
2022
Q1
$561K Buy
10,885
+128
+1% +$6.64K 0.51% 55
2021
Q4
$609K Sell
10,757
-77
-0.7% -$3.82K 0.53% 52
2021
Q3
$465K Hold
10,834
– – 0.45% 64

Other funds holding PFE

Bullock Wealth Management's PFE Position: Q3 2026 in Review

Bullock Wealth Management increased its Pfizer (PFE) stake by 0.38% in Q3 2026, buying an estimated $266 and bringing the position to 2,640 shares worth $74.2K. The position accounts for 0.03% of the portfolio, ranked #245.

Bullock Wealth Management first reported a position in PFE in Q3 2021 and has held it in 21 quarters since. The position peaked at $609K in Q4 2021. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Bullock Wealth Management held 2,640 shares of Pfizer worth $74.2K as of Q3 2026.
  • Bullock Wealth Management bought 10 Pfizer shares in Q3 2026, an estimated $266.
  • Pfizer made up 0.03% of Bullock Wealth Management's portfolio in Q3 2026, its #245 holding.
  • Bullock Wealth Management first reported a position in Pfizer in Q3 2021 and has held it in 21 quarters since.
  • Bullock Wealth Management's Pfizer position peaked at $609K in Q4 2021.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Bullock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.